PLAUR and breast carcinoma: In breast cancer, elevated uPAR expression is an independent prognostic marker of shortened relapse-free survival, metastases-free survival, and overall survival [30-32], although specific therapeutic agents have not been developed for these uPAR-overexpressing patients.